サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1512681

産後プロバイオティクスサプリメントの世界市場：2024年～2031年

Global Postnatal Probiotic Supplements Market - 2024-2031

出版日
ページ情報
英文 219 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
産後プロバイオティクスサプリメントの世界市場：2024年～2031年
出版日: 2024年07月10日
発行: DataM Intelligence
ページ情報: 英文 219 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の産後プロバイオティクスサプリメント市場は、2023年に1,910万米ドルに達し、2031年には3,290万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは8.1%で成長する見込みです。

産後プロバイオティクスサプリメント市場は、広範な栄養補助食品業界の中で、特に産後の新米母親の健康ニーズに応える重要なセグメントとして浮上しています。これらのサプリメントは、母親の健康をサポートし、産後の回復を助け、母乳育児の母親の授乳を促進するように設計されています。市場成長を促進する主な要因としては、プロバイオティクスの健康効果に対する認識の高まり、自然な健康ソリューションに対する消費者の需要の高まり、ヘルスケア専門家による推薦などが挙げられます。

産後用のプロバイオティクスサプリメントには通常、乳酸菌やビフィズス菌などの菌株が含まれており、腸の健康を促進し、免疫系を強化し、消化器系の不快感など産後によくある問題を緩和する可能性があることで知られています。市場の拡大は、プロバイオティクスが妊産婦と新生児の健康増進に果たす役割を強調する調査結果も後押ししており、自分と新生児の健康をサポートする安全で効果的な方法を求める新米母親の間で、プロバイオティクスの採用が進んでいます。

産後プロバイオティクスサプリメント市場では、一般的な健康と授乳をサポートするプロバイオティクス分野が31.14％以上のシェアを占めています。同様に、アジア太平洋は産後プロバイオティクスサプリメント市場を独占し、1/3以上の最大の市場シェアを獲得しています。アジア太平洋地域における産後プロバイオティクスサプリメントの需要は、人口動態の変化、文化的影響、消費者の健康意識の高まりによって力強い成長を遂げています。

ダイナミクス

産後の健康とウェルネスに対する意識の高まり

産後6週間（42日間）は妊産婦の健康にとって極めて重要です。世界保健機関（WHO）によると、世界の妊産婦死亡の60％以上はこの産褥期に発生しており、その4分の3は出産後1週間以内に起きています。この統計は、産後ケアの重要性を強調し、この脆弱な時期に効果的な保健介入を行う必要性を浮き彫りにしています。

産後の健康とウェルネスに対する意識の高まりは、消化器系の健康をサポートし、免疫力を高め、気分の調整を助ける可能性が認められているプロバイオティクスサプリメントの需要を牽引しています。このような意識の高まりは、ヘルスケアプロバイダーや健康団体が、出産後の全体的な健康を促進するプロバイオティクスの利点を強調する教育活動によって後押しされています。

産後用プロバイオティクスサプリメント市場は、製品処方の革新と安全性と有効性を保証する規制基準に支えられて拡大しており、世界中の新米母親の特定の健康ニーズに応えることで継続的な成長が見込まれています。各社は、プロバイオティクスサプリメントで産後の女性特有のニーズを満たすべく技術革新を進めています。これには、出産後の腸の健康と免疫機能に役立つことが知られている菌株を配合した製品も含まれます。

プロバイオティクスの効果を裏付ける科学的証拠の増加

科学的調査により、特に産後ケアにおけるプロバイオティクスの健康促進効果がますます実証されつつあります。研究では、プロバイオティクスが消化器系の健康と免疫機能に不可欠な腸内細菌叢の健康的なバランスを回復・維持するのに役立つことが強調されています。さらに、プロバイオティクスは、便秘、下痢、膣感染といった産後によく見られる問題を軽減する可能性も示しています。こうしたエビデンスの積み重ねが、消費者の認識を形成し、産後用プロバイオティクスサプリメントの需要を牽引しています。

プロバイオティクスは、特に産後の女性に関連する特定の健康上の利点を提供します。これには、出産による生理的ストレス後の腸内健康の回復をサポートすること、重要な回復期に免疫機能を高めること、腸脳軸を通じて気分を改善する可能性があることなどが含まれます。このような利点は、臨床試験や研究によってますます裏付けられてきており、産後の健康管理におけるプロバイオティクス補給の有効性をさらに立証しています。

規制上の課題とコンプライアンスの問題

産後プロバイオティクスサプリメント市場は、その潜在的な健康効果に対する認識が高まっているにもかかわらず、規制上の課題とコンプライアンスの問題が大きな抑制要因となっています。プロバイオティクスを含む栄養補助食品に対する規制状況は地域や国によって大きく異なり、製品登録、表示要件、健康強調表示の立証の面でメーカーに複雑さをもたらしています。

米国や欧州連合を含む多くの管轄区域では、プロバイオティクス補助食品は栄養補助食品に分類されるため、消費者の安全性と製品の品質を保証する規制の対象となります。適正製造基準（GMP）と厳格な試験プロトコルの遵守は、製造業者にとって製造コストと業務上の複雑さを増します。さらに、臨床試験と立証された健康強調表示が必要なため、産後の健康を目的とした新しいプロバイオティクス製剤の市場投入までの時間がさらに長くなります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 産後の健康とウェルネスに対する意識の高まり
      • プロバイオティクスの効果を裏付ける科学的証拠の増加
    • 抑制要因
      • 規制上の課題とコンプライアンスの問題
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品タイプ別

  • 単一菌株プロバイオティクス
  • 多菌株プロバイオティクス
  • プロバイオティクスブレンド
  • プレバイオティクスとプロバイオティクスの組み合わせ
  • その他

第8章 形状別

  • 錠剤
  • 粉末
  • グミ
  • その他

第9章 用途別

  • 免疫健康
  • 消化器系の健康
  • 健康維持と授乳サポート
  • 体重管理
  • その他

第10章 エンドユーザー別

  • 授乳中の女性
  • 産後の女性

第11章 流通チャネル別

  • オンライン
  • オフライン

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • Danone S.A.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Nestle S.A.
  • Chr. Hansen Holding A/S
  • Probi AB
  • BioGaia AB
  • Jarrow Formulas, Inc.
  • Church & Dwight Co., Inc.
  • Renew Life
  • Archer Daniels Midland Company
  • i-Health, Inc.

第15章 企業概要付録

目次
Product Code: FB8524

Overview

Global Postnatal Probiotic Supplements Market reached US$ 19.1 million in 2023 and is expected to reach US$ 32.9 million by 2031, growing with a CAGR of 8.1% during the forecast period 2024-2031.

The postnatal probiotic supplements market has emerged as a significant segment within the broader dietary supplement industry, catering specifically to the health needs of new mothers during the postpartum period. These supplements are designed to support maternal health, aid in recovery after childbirth, and enhance lactation for breastfeeding mothers. Key factors driving market growth include increasing awareness of probiotics' health benefits, rising consumer demand for natural health solutions, and endorsements from healthcare professionals.

Probiotic supplements for postnatal use typically contain strains such as Lactobacillus and Bifidobacterium, known for their ability to promote gut health, strengthen the immune system, and potentially alleviate common postpartum issues like digestive discomfort. Market expansion is also propelled by research highlighting probiotics' role in enhancing maternal and infant health outcomes, thereby encouraging their adoption among new mothers seeking safe and effective ways to support their well-being and that of their newborns.

The general well-being and lactation support probiotic segment in postnatal probiotic supplements market accounts over 31.14% share. Similarly, Asia-Pacific dominates the postnatal probiotic supplements market, capturing the largest market share of over 1/3rd. The demand for postnatal probiotic supplements in the Asia-Pacific region is witnessing robust growth driven by demographic shifts, cultural influences, and increasing health consciousness among consumers.

Dynamics

Rising Awareness of Postnatal Health and Wellness

The postnatal period, spanning the first 6 weeks (42 days) after childbirth, is crucial for maternal health. According to the World Health Organization (WHO), over 60% of global maternal deaths occur during this postpartum phase, with three-fourths of these deaths occurring within the first week after delivery. This statistic underscores the critical importance of postpartum care and highlights the need for effective health interventions during this vulnerable period.

Rising awareness of postnatal health and wellness has consequently driven demand for probiotic supplements, which are recognized for their potential to support digestive health, boost immunity, and aid in mood regulation. This growing awareness is bolstered by educational efforts from healthcare providers and health organizations, emphasizing the benefits of probiotics in promoting overall well-being post-childbirth.

As the market for postnatal probiotic supplements expands, supported by innovations in product formulation and regulatory standards ensuring safety and efficacy, it is poised for continued growth in meeting the specific health needs of new mothers worldwide. Companies are innovating to meet the specific needs of postnatal women with probiotic supplements. This includes formulating products with strains known to benefit gut health and immune function post-childbirth.

Growing Scientific Evidence Supporting Probiotic Benefits

Scientific research has increasingly demonstrated the benefits of probiotics in promoting health, particularly in the context of postnatal care. Studies highlight that probiotics can help restore and maintain a healthy balance of gut microbiota, which is crucial for digestive health and immune function. Moreover, probiotics have shown potential in mitigating common postpartum issues such as constipation, diarrhea, and vaginal infections. This growing body of evidence is instrumental in shaping consumer perceptions and driving demand for postnatal probiotic supplements.

Probiotics offer specific health benefits that are particularly relevant to postnatal women. These include supporting the restoration of gut health following the physiological stresses of childbirth, enhancing immune function during a critical recovery period, and potentially improving mood through the gut-brain axis. Such benefits are increasingly supported by clinical trials and studies, further validating the efficacy of probiotic supplementation in postpartum health management.

Regulatory Challenges and Compliance Issues

Regulatory challenges and compliance issues pose significant restraints to the postnatal probiotic supplements market, despite growing awareness of their potential health benefits. The regulatory landscape for dietary supplements, including probiotics, varies widely across different regions and countries, creating complexities for manufacturers in terms of product registration, labeling requirements, and health claims substantiation.

In many jurisdictions, including the United States and European Union, probiotic supplements are categorized as dietary supplements and thus subject to regulations ensuring consumer safety and product quality. Compliance with Good Manufacturing Practices (GMP) and rigorous testing protocols adds to production costs and operational complexities for manufacturers. Moreover, the need for clinical trials and substantiated health claims further lengthens the time to market for new probiotic formulations aimed at postnatal health.

Segment Analysis

The global postnatal probiotic supplements market is segmented based on product type, form, distribution channel, end-user and region.

The Surging Demand for Lactating Probiotics

Postnatal probiotic supplements are increasingly sought after for their potential to support overall maternal health and well-being. These supplements often contain probiotic strains that help maintain a healthy gut microbiota balance, which is crucial for digestive health and immune function. New mothers prioritize supplements that can boost their energy levels, support recovery after childbirth, and aid in managing postpartum symptoms such as fatigue and stress.

Probiotic supplements designed for lactation support are particularly valued for their ability to promote breast milk production and quality. Certain probiotic strains, such as Lactobacillus fermentum and Lactobacillus salivarius, have been studied for their potential to enhance lactation by influencing mammary gland health and milk composition. These supplements aim to address common lactation challenges faced by new mothers, including insufficient milk supply and related breastfeeding difficulties.

In July 2023, Danone S.A, a global nutrition food company has used its expertise in breastmilk research and breastfeeding to develop Almimama, a probiotic supplement that can help reduce the incidence of mastitis. Affecting approximately one in four mothers, mastitis causes flu-like symptoms and breast pain, as well as skin rashes, fever, and breast engorgement. Breastmilk is widely recognized as nature's most powerful nutrition and tailormade for a baby's needs, providing many short- and long-term benefits for both babies and mothers.

Geographical Penetration

Demand for Postnatal Probiotic Supplements in Asia-Pacific

Asia-Pacific countries such as China, India, and Japan are experiencing rising birth rates and a growing emphasis on maternal and child health. This demographic trend is a significant driver for the demand for nutritional supplements, including probiotics, which are recognized for their potential to support maternal health during the postnatal period and enhance infant development.

Culturally, countries like China and India place strong emphasis on maternal well-being and the health of newborns. Probiotics are increasingly sought after due to their perceived benefits in promoting gut health, bolstering immune function, and aligning with traditional healthcare practices that prioritize natural remedies and preventive health measures.

Healthcare professionals and nutrition experts in the region are increasingly recommending probiotics to new mothers as part of comprehensive postnatal care regimens. These supplements are valued for their potential to improve digestive health, reduce the incidence of allergies in infants, and strengthen immunity during the critical early stages of life.

In May 2024, Probi strengthen its position in the Asia-Pacific region through strong customer collaborations. Probi held the first Probi CID in Shanghai to strengthen its relations and collaborations with customers. More than 30 customers participated, and presentations about the company's China strategic focus and capabilities were presented together with their product solutions, new clinical studies, and coming innovation pipeline.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the postnatal probiotic supplements market, both positively and negatively. On the positive side, heightened health awareness during the pandemic has led to increased consumer interest in health and wellness products, including probiotics.

Many consumers have turned to dietary supplements to boost their immune systems, support overall health, and manage stress, leading to a surge in demand for probiotic products. This trend has been particularly pronounced among new mothers seeking to enhance their postpartum health and well-being, driving growth in the postnatal probiotic supplements market.

On the negative side, the pandemic has caused significant disruptions to global supply chains, affecting the availability and cost of raw materials necessary for probiotic supplements. Lockdowns, travel restrictions, and labor shortages have hampered manufacturing and distribution processes, leading to delays and increased costs. Additionally, the economic downturn induced by the pandemic has affected consumer purchasing power, potentially limiting the market growth as some consumers may cut back on non-essential spending.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has had significant repercussions on the global supply chain, impacting the postnatal probiotic supplements market. Both countries are major producers and suppliers of various raw materials and ingredients used in dietary supplements, including probiotics. The conflict has led to disruptions in the production and export of these critical components, resulting in supply shortages and increased production costs for manufacturers worldwide.

The instability in the region has also caused fluctuations in energy prices, further driving up manufacturing and distribution costs. Consequently, companies in the postnatal probiotic supplements market have faced challenges in maintaining consistent supply and managing increased costs, which can affect product pricing and availability for consumers.

Moreover, the geopolitical tension has influenced market dynamics by creating uncertainty and affecting consumer confidence. Economic sanctions and trade restrictions imposed on Russia have complicated international trade and business operations, causing delays and uncertainties in market activities. This has particularly impacted European markets, where the dependence on Eastern European raw materials is substantial.

By Product Type

  • Single-Strain Probiotics
  • Multi-Strain Probiotics
  • Probiotic Blends
  • Prebiotics and Probiotics Combinations
  • Others

By Form

  • Tablets
  • Powder
  • Gummies
  • Others

By Application

  • Immune Health
  • Digestive Health
  • General Well-being and Lactation Support
  • Weight Management
  • Others

By Distribution Channel

  • Online
  • Offline

By End-User

  • Lactating Women
  • Postpartum Women

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Supplement company Ritual has expanded its pregnancy line with the launch of Natal Choline, which is formulated to support babies' cognitive function when taken during pregnancy. Over 95% of pregnant women, and 90% of women over the age of 19, aren't reaching recommended daily intakes of choline from diet alone, the company reports.
  • In July 2023, Danone has used its expertise in breastmilk research and breastfeeding and developed Almimama, a probiotic supplement that can help reduce the incidence of mastitis. Affecting approximately one in four mothers1, mastitis (inflammation in the breast) causes flu-like symptoms and breast pain, as well as skin rashes, fever and breast engorgement.

Competitive Landscape

The major global players in the market include Danone S.A., Nestle S.A., Chr. Hansen Holding A/S, Probi AB, BioGaia AB, Jarrow Formulas, Inc., Church & Dwight Co., Inc., Renew Life, Archer Daniels Midland Company and i-Health, Inc.

Why Purchase the Report?

  • To visualize the global postnatal probiotic supplements market segmentation based on product type, form, application, end-user, distribution channel and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of postnatal probiotic supplements market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global postnatal probiotic supplements market report would provide approximately 78 tables, 75 figures, and 219 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet By Product Type
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Distribution Channel
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Awareness of Postnatal Health and Wellness
      • 4.1.1.2. Growing Scientific Evidence Supporting Probiotic Benefits
    • 4.1.2. Restraints
      • 4.1.2.1. Regulatory Challenges and Compliance Issues
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Single-Strain Probiotics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Multi-Strain Probiotics
  • 7.4. Probiotic Blends
  • 7.5. Prebiotics and Probiotics Combinations
  • 7.6. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Tablets*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Powder
  • 8.4. Gummies
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Immune Health*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Digestive Health
  • 9.4. General Well-being and Lactation Support
  • 9.5. Weight Management
  • 9.6. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Lactating Women*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Postpartum Women

11. By Distribution Channel

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2. Market Attractiveness Index, By Distribution Channel
  • 11.2. Online*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Offline

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. UK
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Danone S.A. *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Nestle S.A.
  • 14.3. Chr. Hansen Holding A/S
  • 14.4. Probi AB
  • 14.5. BioGaia AB
  • 14.6. Jarrow Formulas, Inc.
  • 14.7. Church & Dwight Co., Inc.
  • 14.8. Renew Life
  • 14.9. Archer Daniels Midland Company
  • 14.10. i-Health, Inc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us